Notable Labs Total Liabilities and Share Holders Equity 2013-2024 | NTBLQ
Notable Labs total liabilities and share holders equity from 2013 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Notable Labs Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023 |
$20 |
| 2022 |
$6 |
| 2021 |
$65 |
| 2020 |
$42 |
| 2019 |
$49 |
| 2018 |
$61 |
| 2017 |
$66 |
| 2016 |
$47 |
| 2015 |
$39 |
| 2014 |
$38 |
| 2013 |
$12 |
| 2012 |
$0 |
Notable Labs Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-06-30 |
$11 |
| 2024-03-31 |
$16 |
| 2023-12-31 |
$20 |
| 2023-09-30 |
$21 |
| 2023-06-30 |
$25 |
| 2023-03-31 |
$28 |
| 2022-12-31 |
$6 |
| 2022-09-30 |
$36 |
| 2022-06-30 |
$45 |
| 2022-03-31 |
$56 |
| 2021-12-31 |
$65 |
| 2021-09-30 |
$61 |
| 2021-06-30 |
$67 |
| 2021-03-31 |
$47 |
| 2020-12-31 |
$42 |
| 2020-09-30 |
$48 |
| 2020-06-30 |
$53 |
| 2020-03-31 |
$43 |
| 2019-12-31 |
$49 |
| 2019-09-30 |
$53 |
| 2019-06-30 |
$57 |
| 2019-03-31 |
$60 |
| 2018-12-31 |
$61 |
| 2018-09-30 |
$64 |
| 2018-06-30 |
$70 |
| 2018-03-31 |
$60 |
| 2017-12-31 |
$66 |
| 2017-09-30 |
$35 |
| 2017-06-30 |
$41 |
| 2017-03-31 |
$43 |
| 2016-12-31 |
$47 |
| 2016-09-30 |
$50 |
| 2016-06-30 |
$54 |
| 2016-03-31 |
$35 |
| 2015-12-31 |
$39 |
| 2015-09-30 |
$29 |
| 2015-06-30 |
$33 |
| 2015-03-31 |
$35 |
| 2014-12-31 |
$38 |
| 2014-09-30 |
$9 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$12 |
| 2013-09-30 |
|
| 2012-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
